Sze Chern Lim

Sze Chern Lim

Auto-generated profile, based on publicly available information

Sze Chern Lim

Centre for Genetic Diseases, Hudson Institute of Medical Research, 3168, Melbourne, Australia

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 January 2012 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
SCSarah E. Calvo
Sarah E. Calvo
ACAlison G Compton
Alison G Compton
SHSteven G. Hershman
Steven G. Hershman
SLSze Chern Lim
Sze Chern Lim
DLDaniel S. Lieber
Daniel S. Lieber
VMVamsi K. Mootha
Vamsi K. Mootha
Advances in next-generation sequencing (NGS) promise to facilitate diagnosis of inherited disorders. Although in research settings NGS has pinpointed causal alleles using segregation in large families, the key challenge for clinical diagnosis is application to single individuals. To explore its diagnostic use, we performed targeted NGS in 42 unrelated infants with clinical and biochemical evidence of mitochondrial oxidative phosphorylation disease. These devastating mitochondrial disorders are characterized by phenotypic and genetic heterogeneity, with more than 100 causal genes identified to date. We performed “MitoExome” sequencing of the mitochondrial DNA (mtDNA) and exons of ~1000 nuclear genes encoding mitochondrial proteins and prioritized rare mutations predicted to disrupt function. Because patients and healthy control individuals harbored a comparable number of such heterozygous alleles, we could not prioritize dominant-acting genes. However, patients showed a fivefold enrichment of genes with two such mutations that could underlie recessive disease. In total, 23 of 42 (55%) patients harbored such recessive genes or pathogenic mtDNA variants. Firm diagnoses were enabled in 10 patients (24%) who had mutations in genes previously linked to disease. Thirteen patients (31%) had mutations in nuclear genes not previously linked to disease. The pathogenicity of two such genes, NDUFB3 and AGK, was supported by complementation studies and evidence from multiple patients, respectively. The results underscore the potential and challenges of deploying NGS in clinical settings.

1 July 2010 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
LRLisa G. Riley
Lisa G. Riley
SCSandra Cooper
Sandra Cooper
PHPeter Hickey
Peter Hickey
JRJoëlle Rudinger-Thirion
Joëlle Rudinger-Thirion
MMMatthew McKenzie
Matthew McKenzie
JCJohn Christodoulou
John Christodoulou

28 June 2013 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
SLSze Chern Lim
Sze Chern Lim
MFMartin Friemel
Martin Friemel
JMJustine E. Marum
Justine E. Marum
ETElena J Tucker
Elena J Tucker
DBDamien L. Bruno
Damien L. Bruno
ACAlison G Compton
Alison G Compton
Iron–sulfur clusters (ISCs) are important prosthetic groups that define the functions of many proteins. Proteins with ISCs (called iron–sulfur or Fe–S proteins) are present in mitochondria, the cytosol, the endoplasmic reticulum and the nucleus. They participate in various biological pathways including oxidative phosphorylation (OXPHOS), the citric acid cycle, iron homeostasis, heme biosynthesis and DNA repair. Here, we report a homozygous mutation in LYRM4 in two patients with combined OXPHOS deficiency. LYRM4 encodes the ISD11 protein, which forms a complex with, and stabilizes, the sulfur donor NFS1. The homozygous mutation (c.203G>T, p.R68L) was identified via massively parallel sequencing of >1000 mitochondrial genes (MitoExome sequencing) in a patient with deficiency of complexes I, II and III in muscle and liver. These three complexes contain ISCs. Sanger sequencing identified the same mutation in his similarly affected cousin, who had a more severe phenotype and died while a neonate. Complex IV was also deficient in her skeletal muscle. Several other Fe–S proteins were also affected in both patients, including the aconitases and ferrochelatase. Mutant ISD11 only partially complemented for an ISD11 deletion in yeast. Our in vitro studies showed that the l-cysteine desulfurase activity of NFS1 was barely present when co-expressed with mutant ISD11. Our findings are consistent with a defect in the early step of ISC assembly affecting a broad variety of Fe–S proteins. The differences in biochemical and clinical features between the two patients may relate to limited availability of cysteine in the newborn period and suggest a potential approach to therapy.

9 January 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SLSze Chern Lim
Sze Chern Lim
MTMakiko Tajika
Makiko Tajika
MSMasaru Shimura
Masaru Shimura
KCKirstyn T. Carey
Kirstyn T. Carey
DSDavid Arthur Stroud
David Arthur Stroud
MMMatthew McKenzie
Matthew McKenzie
Medium-chain acyl-Coenzyme A dehydrogenase (MCAD) is involved in the initial step of mitochondrial fatty acid β-oxidation (FAO). Loss of function results in MCAD deficiency, a disorder that usually presents in childhood with hypoketotic hypoglycemia, vomiting and lethargy. While the disruption of mitochondrial fatty acid metabolism is the primary metabolic defect, secondary defects in mitochondrial oxidative phosphorylation (OXPHOS) may also contribute to disease pathogenesis. Therefore, we examined OXPHOS activity and stability in MCAD-deficient patient fibroblasts that have no detectable MCAD protein. We found a deficit in mitochondrial oxygen consumption, with reduced steady-state levels of OXPHOS complexes I, III and IV, as well as the OXPHOS supercomplex. To examine the mechanisms involved, we generated an MCAD knockout (KO) using human 143B osteosarcoma cells. These cells also exhibited defects in OXPHOS complex function and steady-state levels, as well as disrupted biogenesis of newly-translated OXPHOS subunits. Overall, our findings suggest that the loss of MCAD is associated with a reduction in steady-state OXPHOS complex levels, resulting in secondary defects in OXPHOS function which may contribute to the pathology of MCAD deficiency.

1 February 2014 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
SLSze Chern Lim
Sze Chern Lim
KSKatherine R. Smith
Katherine R. Smith
DSDavid Arthur Stroud
David Arthur Stroud
ACAlison G Compton
Alison G Compton
ETElena J Tucker
Elena J Tucker
DTDavid R. Thorburn
David R. Thorburn

29 February 2016 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
SLSze Chern Lim
Sze Chern Lim
JHJana Hroudová
Jana Hroudová
NBNicole J. Van Bergen
Nicole J. Van Bergen
ISIsabel Lopez Sanchez
Isabel Lopez Sanchez
ITIan A. Trounce
Ian A. Trounce
MMMatthew McKenzie
Matthew McKenzie
Mitochondrial complex I (NADH:ubiquinone oxidoreductase) must be assembled precisely from 45 protein subunits for it to function correctly. One of its mitochondrial DNA (mtDNA) encoded subunits, ND1, is incorporated during the early stages of complex I assembly. However, little is known about how mutations in ND1 affect this assembly process. We found that in human 143B cybrid cells carrying a homoplasmic MT‐ND1 mutation, ND1 protein could not be translated. As a result, the early stages of complex I assembly were disrupted, with mature complex I undetectable and complex I–linked respiration severely reduced to 2.0% of control levels. Interestingly, complex IV (ferrocytochrome c :oxygen oxidoreductase) steady‐state levels were also reduced to 40.3%, possibly due to its diminished stability in the absence of respiratory supercomplex formation. This was in comparison with 143B cybrid controls (that contained wild‐type mtDNA on the same nuclear background), which exhibited normal complex I, complex IV, and supercomplex assembly. We conclude that the loss of ND1 stalls complex I assembly during the early stages of its biogenesis, which not only results in the loss of mature complex I but also disrupts the stability of complex IV and the respiratory supercomplex to cause mitochondrial dysfunction.—Lim, S. C., Hroudová, J., Van Bergen, N. J., Lopez Sanchez, M. I. G., Trounce, I. A., McKenzie, M. Loss of mitochondrial DNA‐encoded protein ND1 results in disruption of complex I biogenesis during early stages of assembly. FASEB J. 30, 2236–2248 (2016). www.fasebj.org